Clinical trial
Early Assessment of Response to Targeted Breast Cancer Therapy
NCT00362973 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Assessment of Response to Targeted Breast Cancer Therapy
- Lead sponsor
- University of Washington
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- Not reported
- Enrollment
- 42 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer